Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)

Gauri Khorjekar, Douglas Van Nostrand, Richard Vetter, Matthew Ringel, Elizabeth Carter and Gary Bloom
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1580;
Gauri Khorjekar
1Nucl Med, Wash Hosp Ctr, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Van Nostrand
1Nucl Med, Wash Hosp Ctr, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Vetter
2Ohio State U, Columbus, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Ringel
3Mayo Clinic, Rochester, MN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Carter
4Medstar Res Inst, Hyattsville, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Bloom
5ThyCa, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1580

Objectives Many controversies exist regarding I-131 tx performed as either an inpt or outpt. One controversy involves the potential that a pt may vomit shortly after administration of I-131 when not in the hospital. The objective of this study is to evaluate the frequency, severity, time of onset, and duration of vomiting after outpt I-131 tx in pts who have WDTC.

Methods A survey involving I-131 tx was e-mailed to associates of the Thyroid Cancer Survivors’ Association and available to anyone on its website. Responses of pts with WDTC who had a least one outpt I-131 tx and were tx’ed in the United States or its territories (US) were tabulated for the aforementioned questions. Only responses by the pt for their most recent I-131 outpt tx were included.

Results Out of 15,000 surveys sent out, 1299 pts responded. Of these, 831 had at least one outpt I-131 tx in the US. Of 801 responses, 81(10%) had vomiting. Of 75 responses, vomiting was categorized as mild 19(25%), moderate 32(42%), and severe 24(32%). Of 73 responses, the times of vomiting after I-131 tx were <30min 3(4%), 0<1hr 0(0%), 1<2hrs 5(6.8%), 2<3hrs 5(6.85), 3<4hrs 9(12%), 4<5hrs 7(9.5%), 5<6hrs 6(8%), 6<12 hr 3(4%), 12<18 hr 3(4%), 18<24 hr 11(15%), 24<48 hr 4(5%), 48<72 hr 6(8%), >72 hr 11(15%). During the first 3 & 4 hrs after administration of I-131, vomiting occurred in 1.8% & 3%, respectively. The duration of vomiting for 73 responders was 0<1hr 17(23%), 1<2hr 8(10.9%), 2<3hr 10(13.7%), 3<4hr 4(5.4%), 4<5hr 0(0%), 5<6hr 0(0%), 6<12hr 5(7%), 12<18hr 3(4%), 18<24hr 5(7%), 24<48hr 5(7%), 48<72hr 7(9%), >72hr 9(12%).

Conclusions Although the frequency of vomiting outside of the hospital in the first 3 to 4 hours is low in the responders to this survey, we believe that because the patient is being administered I-131 in the range of 33 to 200 mCi or more, a period of observation in the tx facility of at least 3 hrs is warranted

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
Gauri Khorjekar, Douglas Van Nostrand, Richard Vetter, Matthew Ringel, Elizabeth Carter, Gary Bloom
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1580;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
Gauri Khorjekar, Douglas Van Nostrand, Richard Vetter, Matthew Ringel, Elizabeth Carter, Gary Bloom
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1580;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
Show more General Clinical Specialties: Endocrinology

Endocrinology Posters

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
Show more Endocrinology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire